METTL3 facilitates kidney injury through promoting IRF4-mediated plasma cell infiltration via an m6A-dependent manner in systemic lupus erythematosus

被引:3
作者
Liu, Yu [1 ]
Wang, Xiaohua [1 ]
Huang, Mingcheng [1 ]
Luo, Ailing [2 ]
Liu, Shanshan [2 ]
Cai, Mansi [2 ]
Li, Weinian [3 ]
Yuan, Shiwen [3 ]
Zheng, Zhihua [1 ]
Liu, Xiaoping [2 ]
Tang, Chun [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 7, Ctr Kidney & Urol, Dept Nephrol, Shenzhen 518107, Peoples R China
[2] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangdong Prov Clin Res Ctr Child Hlth, Dept Hematol, Guangzhou 510623, Peoples R China
[3] South China Univ Technol, Guangzhou Peoples Hosp 1, Dept Rheumatol, Guangzhou 510623, Peoples R China
来源
BMC MEDICINE | 2024年 / 22卷 / 01期
关键词
Systemic lupus erythematosus; Kidney injury; Plasma cell; N6-methyladenosine; Interferon regulatory factor; NEPHRITIS; IRF4;
D O I
10.1186/s12916-024-03735-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundSystemic lupus erythematosus (SLE) is an autoimmune disease of unknown cause. N6-methyladenosine (m6A) is the most common mRNA modification and participates in various immune processes such as interferon production and immune cell regulation. However, the role of m6A in dysregulated immune response of SLE remains unknown.MethodsPBMCs from SLE patients were collected to compare the m6A modification profile by methylated RNA immunoprecipitation sequencing (MeRIP-seq). Interferon regulatory factor 4 (IRF4) was identified by combination with MeRIP-seq and RNA-Seq. IRF4 and methyltransferase 3 (METTL3) were detected using qRT-PCR and WB. Clinical significance of IRF4 in SLE patients was explored subsequently. IRF4 expression in B cell subsets of female MRL/lpr mice was detected by flow cytometry. Adeno-associated viruses (AAV) including AAV9-METTL3-OE and/or AAV9-IRF4-sh were treated with female MRL/lpr mice. Autoantibody levels and kidney injury were tested by ELISA, pathological staining, and immunofluorescence. m6A level of IRF4 was detected by MeRIP-qPCR. The downstream effectors of IRF4 contributing to renal pathology were explored by RNA-seq and verified by qRT-PCR.Resultsm6A methylation features were obviously aberrant in SLE patients, and IRF4 was the upregulated gene modified by m6A. METTL3 and IRF4 expressions were elevated in SLE patients and kidney of MRL/lpr mice. Clinical analysis indicated that SLE patients with high IRF4 level were more prone to kidney damage. IRF4 expression was especially increased in plasma cells of MRL/lpr mice. METTL3 induced renal IRF4 expression, plasma creatinine, ANA and urine ALB levels, IgG and C3 deposition, and renal damage and plasma cell infiltration were aggravated in MRL/lpr mice. However, IRF4 depletion could partially reduce METTL3-induced kidney damage. Meanwhile, m6A level of IRF4 elevated with METTL3 overexpression. Also, the expression of Cxcl1, Bcl3, and Fos mRNA were significantly reduced after knockdown of IRF4, which were mainly involved in TNF signaling pathway.ConclusionsOur study confirmed that upregulated METTL3 promoting IRF4 expression in an m6A-dependent manner, thus causing plasma cell infiltration-mediated kidney damage of SLE. This provides new evidence for the role of m6A in SLE kidney injury.
引用
收藏
页数:20
相关论文
共 47 条
  • [1] B-cell therapy in lupus nephritis: an overview
    Almaani, Salem
    Rovin, Brad H.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (01) : 22 - 29
  • [2] Lupus nephritis
    Anders, Hans-Joachim
    Saxena, Ramesh
    Zhao, Ming-hui
    Parodis, Ioannis
    Salmon, Jane E.
    Mohan, Chandra
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
  • [3] Plasma cell differentiation is coupled to division-dependent DNA hypomethylation and gene regulation
    Barwick, Benjamin G.
    Scharer, Christopher D.
    Bally, Alexander P. R.
    Boss, Jeremy M.
    [J]. NATURE IMMUNOLOGY, 2016, 17 (10) : 1216 - +
  • [4] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [5] ALKBH5 Expression could Affect the Function of T Cells in Systemic Lupus Erythematosus Patients: A Case-control Study
    Deng, Li-Jun
    Fang, Xin-Yu
    Wu, Jun
    Li, Qing-Ru
    Mao, Yan-Mei
    Leng, Rui-Xue
    Fan, Yin-Guang
    Ye, Dong-Qing
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (27) : 2270 - 2278
  • [6] Abnormalities of B cell subsets in patients with systemic lupus erythematosus
    Doerner, Thomas
    Jacobi, Annett M.
    Lee, Jisoo
    Lipsky, Peter E.
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2011, 363 (02) : 187 - 197
  • [7] Local Renal Autoantibody Production in Lupus Nephritis
    Espeli, Marion
    Boekers, Susanne
    Giannico, Giovanna
    Dickinson, Harriet A.
    Bardsley, Victoria
    Fogo, Agnes B.
    Smith, Kenneth G. C.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (02): : 296 - 305
  • [8] Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunity
    Fanzo, JC
    Yang, W
    Jang, SY
    Gupta, S
    Chen, QZ
    Siddiq, A
    Greenberg, S
    Pernis, AB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) : 703 - 714
  • [9] Precision medicine in systemic lupus erythematosus
    Fasano, Serena
    Milone, Alessandra
    Nicoletti, Giovanni Francesco
    Isenberg, David A.
    Ciccia, Francesco
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (06) : 331 - 342
  • [10] Tet DNA demethylase is required for plasma cell differentiation by controlling expression levels of IRF4
    Fujii, Kentaro
    Tanaka, Shinya
    Hasegawa, Takanori
    Narazaki, Masashi
    Kumanogoh, Atsushi
    Koseki, Haruhiko
    Kurosaki, Tomohiro
    Ise, Wataru
    [J]. INTERNATIONAL IMMUNOLOGY, 2020, 32 (10) : 683 - 690